Patents by Inventor Heinz Gschwend

Heinz Gschwend has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyridylpiperazines and aminonicotinamides and their use as therapeutic agents
    Patent number: 7390813
    Abstract: Novel compounds useful in the treatment of, prevention of or protection against diseases and/or conditions related to metabolic syndrome and lipid metabolism, especially diseases of fatty acid and cholesterol metabolism, such as those mediated by stearoyl-CoA desaturase, are disclosed along with methods of employing said compounds for such uses.
    Type: Grant
    Filed: December 20, 2002
    Date of Patent: June 24, 2008
    Assignee: Xenon Pharmaceuticals Inc.
    Inventors: Mark P. Gray-Keller, Michael D. Winther, Richard M. Fine, Boris Klebansky, Heinz Gschwend, Daniel F. Harvey
  • Pyridyl derivatives and their use as therapeutic agents
    Publication number: 20060293308
    Abstract: Methods of treating an SCD-mediated disease or condition in a mammal, preferably a human, are disclosed, wherein the methods comprise administering to a mammal in need thereof a compound of formula (I): wherein W, V, x, y, R1, R2, R3, R4, R5, R6, R7, R7a, R8, R8a, R9, R9a, R10 and R10a are defined herein. Pharmaceutical compositions comprising the compounds of formula (I) are also disclosed.
    Type: Application
    Filed: July 29, 2004
    Publication date: December 28, 2006
    Applicant: Xenon Pharmaceuticals Inc.
    Inventors: Melwyn Abreo, Daniel Harvey, Mikhail Kondratenko, Wenbao Li, Rajender Kamboj, Vishnumurthy Rodumuru, Michael Winther, Heinz Gschwend, Nagasres Chakka, Shifeng Liu, Serguei Sviridov, Shaoyi Sun
  • Pyridazine derivatives and their use as therapeutic agents
    Publication number: 20060205713
    Abstract: Methods of treating an SCD-mediated disease or condition in a mammal, preferably a human, are disclosed, wherein the methods comprise administering to a mammal in need thereof a compound of formula (I): where x, y, W, V, R2, R3, R4, R5, R6, R6a, R7, R7a, R8, R8a, R9 and R9a are defined herein. Pharmaceutical compositions comprising the compounds of formula (I) are also disclosed.
    Type: Application
    Filed: July 29, 2004
    Publication date: September 14, 2006
    Applicant: Xenon Pharmaceuticals Inc.
    Inventors: Heinz Gschwend, Vishnumurthy Kodumuru, Shifeng Liu, Rajender Kamboj
  • Pyridazine derivatives and their use as therapeutic agents
    Publication number: 20060009459
    Abstract: Methods of treating an SCD-mediated disease or condition in a mammal, preferably a human, are disclosed, wherein the methods comprise administering to a mammal in need thereof a compound of formula (Ia): where x, y, W, V, R2, R3, R4, R5, R6, R6a, R7, R7a, R8, R8a, R9 and R9a are defined herein. Pharmaceutical compositions comprising the compounds of formula (I) are also disclosed.
    Type: Application
    Filed: February 9, 2005
    Publication date: January 12, 2006
    Inventors: Nagasree Chakka, Mikhail Chafeev, Sultan Chowdhury, Jian-Min Fu, Duanjie Hou, Rajender Kamboj, Vishnumurthy Kodumuru, Shifeng Liu, Vandna Raina, Shaoyi Sun, Serguei Sviridov, Michael Winther, Zaihui Zhang, Melwyn Abreo, Mark Holladay, Wenbao Li, Sengen Sun, Chi Tu, Heinz Gschwend
  • Nicotinamide derivatives and their use as therapeutic agents
    Publication number: 20050119251
    Abstract: Methods of treating an SCD-mediated disease or condition in a mammal, preferably a human, are disclosed, wherein the methods comprise administering to a mammal in need thereof a compound of formula (I): where m, n, p, V, R1, R2, R3, R4, R5 and R6 are defined herein. Pharmaceutical compositions comprising the compounds of formula (I) are also disclosed.
    Type: Application
    Filed: July 6, 2004
    Publication date: June 2, 2005
    Inventors: Jian-Min Fu, Vishnumurthy Kodumuru, Shaoyi Sun, Michael Winther, Richard Fine, Daniel Harvey, Boris Klebansky, Mark Gray-Keller, Heinz Gschwend, Wenbao Li
  • Pyridazine derivatives and their use as therapeutic agents
    Publication number: 20050065143
    Abstract: Methods of treating an SCD-mediated disease or condition in a mammal, preferably a human, are disclosed, wherein the methods comprise administering to a mammal in need thereof a compound of formula (I): where x, y, W, V, R2, R3, R4, R5, R6, R6a, R7, R7a, R8, R8a, R9 and R9a are defined herein. Pharmaceutical compositions comprising the compounds of formula (I) are also disclosed.
    Type: Application
    Filed: July 29, 2004
    Publication date: March 24, 2005
    Applicant: Xenon Pharmaceuticals Inc.
    Inventors: Nagasree Chakka, Mikhail Chafeev, Sultan Chowdhury, Jian-Min Fu, Duanjie Hou, Rajender Kamboj, Vishnumurthy Kodumuru, Shifeng Liu, Vandna Raina, Shaoyi Sun, Serguei Sviridov, Michael Winther, Zaihui Zhang, Melwyn Abreo, Mark Holladay, Wenbao Li, Sengen Sun, Chi Tu, Heinz Gschwend